Skip to main content

Antonio Moreno Galdó

Vaig néixer a Granada i em vaig llicenciar en Medicina i Cirurgia a la Facultat de Medicina de la Universitat de Granada. Vaig realitzar l'especialitat de Pediatria a l'Hospital Universitari Vall d'Hebron de Barcelona (1984-1988) i la tesi doctoral a la Universitat Autònoma de Barcelona. Vaig treballar com a metge adjunt al Servei de Pediatria de l'Hospital Son Dureta de Palma de Mallorca (Espanya) entre els anys 1989 i 1992 i des de 1992 treballo a l'Hospital Universitari Vall d'Hebron.

Institutions of which they are part

Head of group
Growth and Development
Vall Hebron Institut de Recerca
Head of Section
Pneumology, allergology and cystic fibrosis
Children's Hospital and Woman's Hospital

Antonio Moreno Galdó

Institutions of which they are part

Head of group
Growth and Development
Vall Hebron Institut de Recerca
Head of Section
Pneumology, allergology and cystic fibrosis
Children's Hospital and Woman's Hospital

Vaig néixer a Granada i em vaig llicenciar en Medicina i Cirurgia a la Facultat de Medicina de la Universitat de Granada. Vaig realitzar l'especialitat de Pediatria a l'Hospital Universitari Vall d'Hebron de Barcelona (1984-1988) i la tesi doctoral a la Universitat Autònoma de Barcelona. Vaig treballar com a metge adjunt al Servei de Pediatria de l'Hospital Son Dureta de Palma de Mallorca (Espanya) entre els anys 1989 i 1992 i des de 1992 treballo a l'Hospital Universitari Vall d'Hebron.

Entre els anys 1989 i 1997 la meva dedicació professional a l'Hospital Vall d'Hebron va estar dirigida a les Cures Intensives Pediàtriques i des de 1998 em vaig especialitzar en Pneumologia Pediàtrica sent actualment el cap de Secció de les Unitats d'Al·lèrgia, Pneumologia Pediàtrica i Fibrosi Quística de l'Hospital Universitari Vall d'Hebron. Sóc responsable mèdic del programa de trasplantament pulmonar infantil d'aquest hospital que es va iniciar el 1998.
Des de l'any 2006 sóc professor associat i des de l'any 2014 professor titular-agregat de Pediatria de la Universitat Autònoma de Barcelona.
Les meves línies de recerca al VHIR inclouen la inflamació pulmonar en l'asma en lactants i en nens escolars, la funció pulmonar en nens, i l'estudi de les malalties respiratòries pediàtriques rares, com la discinèsia ciliar, la hipertensió pulmonar i les pneumopaties intersticials pediàtriques.

Research lines

Paediatric respiratory diseases.

The Paediatric Pulmonology and Cystic Fibrosis Unit is a Spanish referral center for paediatric lung transplantation and pulmonary hypertension and a Catalonia referral center for children with cystic fibrosis, including the neonatal screening program. The main lines of research include the study of inflammation and bronchial hyperresponsiveness in asthma in infants and older children, the determination of reference values for spirometry in children and the study of lung function in children with sequelae of neonatal respiratory disease (bronchopulmonary dysplasia). The Unit has established a new line of study of ciliary motility and ultrastructure in primary ciliary dyskinesia to allow further study of this rare disease.

IP: Antonio Moreno Galdó

Rare respiratory diseases: Primary ciliary dyskinesia, Paediatric interstitial lung diseases and paediatric pulmonary hypertension.

1.1 Primary ciliary dyskinesia (PCD): We are a referral centre for diagnosis of PCD and we have established a clinical and research collaboration network with other national and international PCD diagnostic centres. 

1.2 Paediatric interstitial lung diseases. We are leading the Spanish ISCIII registry for paediatric interstitial lung diseases and have started a project to characterize the incidence and the molecular basis of these rare diseases in Spain. We have international collaborations in this field (chILD EU registry and an E-rare 3 funded clinical trial).

1.3 Paediatric pulmonary hypertension. We have an active collaboration with the Spanish Registry of Paediatric Pulmonary Hypertension (REHIPED) and are developing an intense epidemiologic research in this area.


IP: Antonio Moreno Galdó

Asthma and recurrent wheezing. Infant and children lung function.

Asthma and recurrent wheezing: Inflammatory markers. Insight into its pathogenesis and treatment.

Infant and children lung function: Reference values and clinical application.

IP: Antonio Moreno Galdó, Inés de Mir Messa

Projects

Creixement i Desenvolupament

IP: Antonio Moreno Galdó
Collaborators: Maria Clemente Leon, Diego Yeste Fernandez, Félix Castillo Salinas, elena sena , Inés de Mir Messa, Ariadna Campos Martorell, Sandra Rovira Amigo, Alba Torrent Vernetta, Ana Díez Izquierdo, Noelia Baz Redón, Nuria Camats Tarruella, SILVIA GARTNER TIZZANO
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00779
Duration: 01/01/2022 - 31/12/2024

Mejorando el diagnóstico de la discinesia ciliar primaria

IP: Antonio Moreno Galdó
Collaborators: -
Funding agency: Fundación Asociación Española de Pediatría
Funding: 25500
Reference: AEP/CLINICA_BASICA/2021/MORENO
Duration: 31/07/2021 - 30/07/2023

Plataforma ISCIII de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Joan Genescà Ferrer, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 315150
Reference: PT20/00078
Duration: 01/01/2021 - 31/12/2024

Primary ciliary dyskinesia in adult bronchiectasis. Diagnostic strategy based on next generation sequencing gene panel analysis.

IP: Antonio Moreno Galdó
Collaborators: Antonio Álvarez Fernandez, David Clofent Alarcón, Sandra Rovira Amigo, Alba Torrent Vernetta, Noelia Baz Redón, Nuria Camats Tarruella
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI20/01419
Duration: 01/01/2021 - 30/06/2025

Related news

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

An international clinical trial has demonstrated the effectiveness of dupilumab in reducing patients’ asthmatic exacerbations, improving their and their relatives quality of life

Related professionals

Sandra  Peiro Sales

Sandra Peiro Sales

Main researcher
Read more
Carme Santoyo Medina

Carme Santoyo Medina

Main researcher
Clinical Neuroimmunology
Read more
Elena Huerga Núñez

Elena Huerga Núñez

Administration and Management
Neuroradiology
Read more
Irene Ortiz Martinez

Irene Ortiz Martinez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.